Drug Type Small molecule drug |
Synonyms- |
Mechanism p300-CBP transcription factors inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H21N5O2 |
InChIKeyXWUXXBXEPKJMQG-UHFFFAOYSA-N |
CAS Registry2640681-46-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Preclinical | CN | 01 Nov 2020 | |
Acute Myeloid Leukemia | Preclinical | CN | 01 Nov 2020 |